Skip to main content
Fig. 13 | Hereditas

Fig. 13

From: N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer

Fig. 13

The relationship between tumor risk score and immunotherapy. A-D The correlation between risk score and different immune scores. E The prognostic difference between the high and low risk score groups. F-G The difference in risk scores between the remission group (CR/PR) and the non-remission group (SD/PD). CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease

Back to article page

Hereditas

ISSN: 1601-5223

Contact us